Group 1 Pretreatment | Group 1 Posttreatment | Effect Size | SRM | p | |||
---|---|---|---|---|---|---|---|
Mean | SD | Mean | SD | ||||
ADC | 0.45 | 0.43 | 0.15 | 0.23 | −0.684 | −0.877 | 0.0017 |
SPARCC | 13.40 | 15.02 | 3.25 | 5.66 | −0.676 | −0.911 | 0.00083 |
ASDAS-CRP | 4.32 | 0.62 | 1.75 | 0.99 | −4.118 | −2.273 | 7.9 × 10−8 |
ASDAS-ESR | 4.29 | 0.69 | 1.72 | 0.99 | −3.701 | −2.372 | 6.3 × 10−8 |
ESR | 41.78 | 24.03 | 12.00 | 12.22 | −1.239 | −1.335 | 6.3 × 10−5 |
CRP | 24.18 | 18.07 | 4.88 | 4.57 | −1.068 | −1.050 | 0.00063 |
BASDAI | 7.94 | 1.13 | 2.01 | 1.72 | −5.237 | −3.396 | 5 × 10−10 |
BASFI | 5.02 | 1.45 | 2.70 | 2.02 | −1.599 | −1.029 | 0.00063 |
BASMI | 2.78 | 2.14 | 1.82 | 2.00 | −0.446 | −0.953 | 0.00095 |
SRM: standardized response mean; ADC: apparent diffusion coefficient; SPARCC: Spondyloarthritis Research Consortium of Canada; BASDAI: Bath Ankylosing Spondylitis Disease Activity Index; ASDAS: Ankylosing Spondylitis Disease Activity Score; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; BASFI: Bath Ankylosing Spondylitis Functional Index; BASMI: Bath Ankylosing Spondylitis Metrology Index.